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Abstract
The present study used a systematic review approach to identify relevant randomised control trials (RCT) with vitamin D and then apply
meta-regression to explore the most appropriate model of the vitamin D intake–serum 25-hydroxyvitamin D (25(OH)D) relationship to
underpin setting reference intake values. Methods included an updated structured search on Ovid MEDLINE; rigorous inclusion/exclusion
criteria; data extraction; and meta-regression (using different model constructs). In particular, priority was given to data from winter-based
RCT performed at latitudes .49·58N (n 12). A combined weighted linear model meta-regression analyses of natural log (Ln) total vitamin D
intake (i.e. diet and supplemental vitamin D) v. achieved serum 25(OH)D in winter (that used by the North American Dietary Reference
Intake Committee) produced a curvilinear relationship (mean (95 % lower CI) serum 25(OH)D (nmol/l) ¼ 9·2 (8·5) Ln (total vitamin D)).
Use of non-transformed total vitamin D intake data (maximum 1400 IU/d; 35mg/d) provided for a more linear relationship (mean serum
25(OH)D (nmol/l) ¼ 0·044 £ (total vitamin D) þ 33·035). Although inputting an intake of 600 IU/d (i.e. the RDA) into the 95 % lower CI
curvilinear and linear models predicted a serum 25(OH)D of 54·4 and 55·2 nmol/l, respectively, the total vitamin D intake that would
achieve 50 (and 40) nmol/l serum 25(OH)D was 359 (111) and 480 (260) IU/d, respectively. Inclusion of 95 % range in the model to account
for inter-individual variability increased the predicted intake of vitamin D needed to maintain serum 25(OH)D $50 nmol/l to 930 IU/d. The
model used to describe the vitamin D intake–status relationship needs to be considered carefully when setting new reference intake values
in the Europe.
Key words: Systematic reviews: Meta-regression: Vitamin D requirements: Serum 25-hydroxyvitamin D: European
Micronutrient Recommendations Aligned (EURRECA)
Severe vitamin D deficiency has been shown to lead to rickets
in children and osteomalacia in adults(1), while less severe
vitamin D deficiency causes secondary hyperparathyroidism,
increased bone turnover and bone loss(2–4), as well as being
associated with increased risk of several non-skeletal chronic
diseases(5,6). Thus, ensuring adequate vitamin D status is
important to human health and there is a consensus that
serum 25-hydroxyvitamin D (25(OH)D) should be used to
assess vitamin D status, as it reflects combined dietary
supply and dermal production(7).
Serum 25(OH)D was used as a functional indicator of vita-
min D status by the recent Institute of Medicine (IOM) dietary
reference intake (DRI) committee on Ca and vitamin D in
North America(8), as well as by the UK and the European
Union authorities(1,9–11) during the 1990s, in establishing diet-
ary requirements for vitamin D. To date, many, if not all,
agencies briefed with establishing dietary requirements for
vitamin D have used a cutoff of 25–30 nmol/l serum
25(OH)D as the lower threshold for vitamin D status (on the
basis of rickets and osteomalacia)(1,8–11). There has been
*Corresponding author: Professor K. D. Cashman, fax þ353 21 4270244, email k.cashman@ucc.ie
Abbreviations: 25(OH)D, 25-hydroxyvitamin D; DRI, dietary reference intake; IOM, Institute of Medicine; Ln, natural log; RCT, randomised control trial;
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an increasing body of data on the relationship between
vitamin D status and a wide range of non-skeletal health out-
comes, and some of these (mainly CVD or cancer outcomes)
were reviewed in a comprehensive systematic review(12), com-
missioned by several US and Canadian federal government
agencies, for use by the DRI committee during their delibera-
tions. However, many of the studies of non-skeletal health
effects provided often mixed and inconclusive results and
led the DRI committee to question their reliability. The DRI
committee instead prioritised bone health outcomes as the
basis for establishing the new DRI values for vitamin D
(and Ca)(8).
For individuals aged 1 year and older, the DRI committee
choose serum 25(OH)D concentrations of 40 and 50 nmol/l
as the median value (above which approximately half the
population might meet vitamin D requirements for bone
health and below which one-half might not) and that covering
the needs of 97·5 % of a normal healthy population, respect-
ively. These served as the target concentrations for an
estimated average requirement and RDA for dietary vitamin D,
respectively(8). The DRI committee then used data from nine
vitamin D intervention studies of individuals aged 6 to .60
years, performed at the northern latitudes in Europe
(.49·58N) and Antarctica (788S) during their respective
winter seasons (with minimal UV blue (UVB) sun exposure)
to establish regression equations of the simulated response
of serum 25(OH)D concentration to total vitamin D intake.
A similar analysis on data from randomised control trials
(RCT) conducted in the latitude band 40 to ,49·58N (all
from the USA) yielded quite different regression equations,
suggesting that UVB exposure during winter was not
minimal(8). The estimated average requirement and RDA for
vitamin D of 10 and 15mg/d (20mg/d for those .70 years),
respectively, were derived from the .49·58N/S RCT regression
analysis to approximate conditions of minimal UVB sun
exposure(8). The DRI committee, however, highlighted that
the regression analysis had several assumptions and/or uncer-
tainties: lack of age effect on the response of serum 25(OH)D
to total vitamin D intake, large inter-study variance and uncer-
tainties surrounding the predicted CI of the vitamin D intake–
status relationship(8), which were used to estimate the DRI
values for vitamin D. Furthermore, it is possible that European
agencies briefed with the task of re-evaluation of DRI for
vitamin D may decide to use a serum 25(OH)D target con-
centration other than 50 nmol/l, which may require a different
regression model.
Thus, the aim of the present study was to use a systematic
review approach to identify relevant RCT with vitamin D in
children/adolescents, adults and older adults, and then apply
meta-regression models (including that used by the DRI
committee(8)) to the extracted data, as well as using individual
data from two recent vitamin D RCT in the northern European
adults and elderly(13,14) during winter, to explore the most
appropriate model of the vitamin D intake–serum 25(OH)D
relationship. In addition, whether latitude influenced this
relationship was investigated, as much of Europe resides
between 40 and .708N.
Methods
Research questions to be addressed by the present analysis
and their rationale
The following key research questions were addressed in the
present regression analysis:
(1) Does latitude (between 40 and 49·58N compared to
$49·58N (and 788S)) influence the response of serum
25(OH)D to increased vitamin D intake during winter?
Rationale: The rationale for choosing RCT that finished
at (or at least reported data from) the end of winter, as
outlined by the IOM, was due to uncertainties about
the contribution of sunlight to overall serum 25(OH)D
concentration and that vitamin D requirements cannot
be based on an accepted or ‘recommended’ level of
sun exposure due to potential skin damage and
cancer(8). Instead, the best remaining approach was to
describe the relationship between total vitamin D intake
and serum 25(OH)D levels under conditions of minimal
sun exposure, as would be achieved in winter time(8),
an approach we have also advocated in our recent
studies of vitamin D dietary requirements(13–15). The
IOM used the two latitude bands (namely, 40 to
,49·58N and $49·58N and 788S) to test the assumption
of minimal sun exposure during winter, which they
found was met in RCT performed in the latter but not
the former latitude region(8). As much of Europe resides
between 40 and .708N, the two latitude bands used
by the IOM seemed appropriate to test in the present
analysis. Finally, the choice of which months should be
designated as winter (during which there is insufficient
UVB sunshine to allow for dermal synthesis of vitamin
D) may differ in these two latitude bands, particularly at
the lower latitude range. Therefore, in addition to testing
the DRI committee’s definition of winter as September to
June or part thereof(8), we also used September to April
as a shorter winter period, as it is highly likely that
there is UVB sunshine of sufficient strength in May and
June to allow for dermal synthesis of vitamin D and
thus could contribute significantly to achieved serum
25(OH)D concentration.
(2) What is the most appropriate model for the relation-
ship between total vitamin D intake and achieved
serum 25(OH)D? Rationale: The DRI committee used an
integrated bone health outcome approach (incor-
porating Ca absorption, bone mineral density, risk of
rickets and osteomalacia) to define the estimated
average requirement-like serum 25(OH)D concentration
(40 nmol/l) and 50 nmol/l as the concentration of
25(OH)D covering the needs of nearly all in the popu-
lation(8). As mentioned previously, it is possible that
European agencies briefed with the task of re-evaluation
of population reference intake (PRI), or member state-
specific equivalent dietary reference values, for vitamin D
may decide to use a serum 25(OH)D target concentration
other than 50 nmol/l. For example, should a European
agency decide to use risk of rickets or osteomalacia as
Vitamin D intake–status relationship 1639
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the health outcome used to establish their dietary
reference value in preference to the more integrated
bone health outcome approach used by the DRI, they
may well use 30 nmol/l, or even the more precautionary
40 nmol/l(8), as the target 25(OH)D concentration on
which to base their intake requirement value. Therefore,
we wished to explore the vitamin D intake–serum
25(OH)D relationship under different meta-regression
model constructs, particularly at different serum 25(OH)D
concentrations.
Systematic review of vitamin D intake–status relationship
The methodology used in the systematic review and meta-
regression in the present study follows the general methodology
for a recent series of systematic reviews in relation to markers of
nutrient status(16) and in particular for our recent systematic
review of existing and potentially novel functional markers of
vitamin D status(17), with brief specific details as follows:
Inclusion criteria. Studies were RCT of vitamin D (D3 with
or without Ca) supplementation in apparently healthy human
subjects or in patients in whom there is no underlying reason
for altered vitamin D metabolism or response to vitamin D
supplementation that fulfilled all of the following charac-
teristics: (1) vitamin D3 #2000 IU/d (50mg/d; 1mg ¼ 40 IU)
administered orally alone or with Ca on a daily basis
(inclusion of vitamin D3 and not D2 was chosen on the basis
that the IOM DRI committee used studies with vitamin D3
in their regression analysis of the northern European RCT
(and Antarctica), on which DRI values were set(8), and there
is still some debate as to the relative potency of vitamin D2
relative to vitamin D3
(18,19); (2) reported serum or plasma
25(OH)D levels following supplementation in at least one
intervention group and one control group; (3) no vitamin D
metabolites (25(OH)D and 1,25(OH)2D) and analogues
(e.g. a-calcidol) co-administered; (4) minimum duration of
6 weeks (on the basis that following initiation of vitamin D
supplementation, serum 25(OH)D concentrations reach equi-
librium after at least 6–8 weeks in adults and elderly
subjects(20,21)); (5) studies performed above 408N (or 408S)
(these minimum latitudes were those used in RCT included
in the regression analysis by the DRI committee(8)); (6) studies
were carried out in children and adolescents (1–18 years),
adults (18–64 years) and older adults (.64 years). (Infants
and pregnant or lactating women are life-stage groups that
have special considerations in relation to vitamin D and
were excluded from the present analysis.)
Search strategy. In our recent systematic review of existing
and potentially novel functional markers of vitamin D
status(17), electronic searches were run (on Ovid MEDLINE
(Ovid, http://www.ovid.com), EMBASE and Cochrane CEN-
TRAL (http://www.thecochranelibrary.com)) from inception
to 25 September 2007 by using a structured search strategy
in the following format: ((vitamin D supplements) AND (sup-
plementation or depletion studies in human subjects)) (details
available online at http://www.ajcn.org/content/vol0/issue2009/
images/data/ajcn.2009·27230D/DC1/AJCN_27230D_ST1.doc for
full Ovid MEDLINE search strategy). As part of that systematic
review, a vitamin D expert was contacted, reference lists
of ten reviews drawn from electronic searches of reviews
run on Ovid MEDLINE and all included studies were checked
and additional articles collected and assessed for inclusion(17).
For the present study, an updated search from 26 September
2007 to 30 November 2010, using the same structured
search strategy, was performed. In addition, there have
been two major systematic reviews performed in the area
of vitamin D (and Ca) and bone(12,22) and other health out-
comes(12), as well as the IOM DRI report on Ca and
vitamin D(8). For completeness, we cross-referenced the
RCT that were both included and excluded in these reviews
against those identified for inclusion or exclusion in the
present study.
Data collection for updated search. Screening of titles and
abstracts for collection, screening full-text articles for inclusion
and data extraction (including quality assessment) from
included studies were all performed by two independent
reviewers. Both reviewers for the updated search were the
same individuals who performed the original electronic
searches(17).
Data synthesis. A flowchart showing the number of
studies assessed (original and updated search) and included
in the review is shown in Fig. 1. We extracted the number
of participants included (and assessed) in each arm of each
RCT, plus mean values and standard deviations of the baseline
and final values in the treatment and control arms at each time
point and for each vitamin D dose. In cases in which there
were greater than or equal to two intervention arms and
one common control group within an RCT, the various arms
(up to and including 2000 IU/d) v. control were included so
long as the arms fell into different dose range subgroups.
Meta-regression of the response of serum 25-hydroxy-
vitamin D to total vitamin D intake. Weighted linear model
meta-regression analyses of total vitamin D intake (i.e. habit-
ual intake of the vitamin plus the supplemental dose) v.
achieved serum or plasma 25(OH)D concentration (i.e. the
concentration at the end of the winter sampling point) were
performed in SPSS for Windows version 15.0 (SPSS, Inc.,
Chicago, IL, USA). As per the analysis by the IOM DRI
committee, the regression analysis in the present study was
performed on data from all RCT that were conducted during
the winter period (September to June or for part thereof,
as defined in the IOM DRI report(8)) stratified by .40 to
,49·58N and $49·58N and 788S.
In situations in which the RCT did not assess and/or report
the habitual vitamin D intake of the cohort(s) within their
study, the appropriate age and sex group mean vitamin D
intake value from the national nutrition survey relevant to
the country in which the RCT was performed, where available
(or where unavailable then from a published study in the rel-
evant sex and age group) was used as a surrogate (Table 1).
The habitual intake estimates were added to the sup-
plemental vitamin D dose to generate total vitamin D intake
estimates, which were then transformed to the natural log
(Ln) before regression analysis, the approach used by
the DRI committee(8). As per the DRI committee approach,
K. D. Cashman et al.1640
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the various vitamin D arms of an RCT were included as long
as the arms fell into different dose range subgroups(8). In
addition, the regression was set for a y0 intercept of 0 nmol
of 25(OH)D/l of serum, on the basis that the DRI committee
suggested that this is consistent with the biological reality pre-
venting a negative value for achieved serum 25(OH)D
levels(8). In addition, regression models of achieved serum
25(OH)D concentration and total vitamin D intake were run
without Ln transforming total intake, but limiting the total vita-
min D intake data points to a maximum of 1400 IU/d, on the
basis of Aloia et al.(23), who in their recent analysis of sixty-
four vitamin D RCT using a spline-fit approach showed that
the slope response of serum 25(OH)D to increasing dose
becomes constant at a dose of 1400 IU/d. Thus, at doses
above this level, the response of serum 25(OH)D is more
blunted and would not be best described by a linear fit model.
Regression analysis of combined individual data from two
winter-based randomised controlled vitamin D intervention
trials in adults and older adults at latitudes .49·58N.
Regression analysis using the same model characteristics
(total vitamin D intake with and without prior Ln transform-
ation, setting y0 intercept of 0 nmol of 25(OH)D/l of serum
(Ln model) or allowing model predict y0 intercept (non-Ln
model)) was performed on individual data from two recently
published randomised, double-blind, placebo-controlled,
vitamin D3 intervention studies in northern European ($528N)
20- to 40-year-old adults (n 238(13)) and greater than 64-year-
old adults (n 225(14)), which estimated the dietary requirement
for vitamin D in these population subgroups during late winter.
Results
In total, 2742 (2363 in our previous review(17) and 379 in our
updated search) titles and abstracts were screened (Fig. 1) and
forty-four RCT were included(4,13–15,19,20,24–62), all of which
met the inclusion criteria of the present study and provided
extractable data on serum or plasma 25(OH)D. Details of the
forty-four included studies (including some criteria of quality)
have been presented in our previous systematic review(17) or
in the Tufts systematic review group(12), the IOM DRI
report(8) or are shown in Table 1. Of the forty-four studies,
seven were in males and twenty-four in females (the remain-
der were mixed). Of the RCT, four were in children and ado-
lescents (8–15 years), eleven in adults (18–64 years) and
twenty-two in elderly (.65 years; some studies had more
than one population subgroup). Among these, twenty-four
studies gave vitamin D supplementation alone, twenty vitamin
D plus Ca (some studies had both arms) and one study co-
administered phylloquinone(30) and one alendronate(32). In
all, five studies gave #200, fifteen 201–400, thirty 401–1000
and six 1001–2000 IU/d of supplemental vitamin D (some
studies provided multiple doses). Of the winter-based RCT,
Titles and abstracts retrieved
from electronic, bibliographic
and expert searches: (2363)
Original review Update
Titles and abstracts very
unlikely to be relevant: (2239)
Titles and abstracts that
appeared potentially relevant,
ordered as full text papers:
(124)
Full papers included: forty (of
which thirty-two measured
25(OH)D concentration):
Of the thirty-two included in
the original review, twenty-five
fit the criteria for the present
analysis (seven did not):
• three supplemented with D2
• two were in at latitudes
<40°N
• one was a duplicate study
• one was in patients with
hyperparathyroidism
Papers excluded: (84)
Not an intervention study: (10)
Supplement not appropriate: (4)
Not minimal duration: (5)
No absolute control group: (14)
Mega-dose/bolus dose
administered: (13)
Mother was supplemented but
infant status measured: (8)
Subjects had secondary
disease: (9)
Improper randomisation: (3)
Unable to extract data: (12)
Study did not include status
marker(s) of choice: (3)
Duplicate study populations
assessed: (3)
Titles and abstracts retrieved
from electronic, bibliographic
and expert searches: (379)
Titles and abstracts very
unlikely to be relevant: (265)
Titles and abstracts that
appeared potentially relevant,
ordered as full text papers:
(114)
Full papers included: (19)
Studies included (publications
of the same studies pooled):
Serum/plasma 25(OH)D:
forty-four studies
Papers excluded: (95)
Not an intervention study: (15)
Supplement not appropriate: (14)
Not minimal duration: (8)
No absolute control group: (16)
Mega-dose/bolus dose
administered: (20)
Mother was supplemented but
infant status measured: (4)
Subjects had secondary
disease: (5)
Infancy/pregnancy/lactation: (4)
Unable to extract data: (2)
Study did not include
25(OH)D: (6)
Duplicate study populations
assessed: (6)
Fig. 1. Flow diagram for systematic review of vitamin D intake–status relationship. 25(OH)D, 25-hydroxyvitamin D; D2, vitamin D2.
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Table 1. Study characteristics of randomised controlled trials .49·58N selected for the meta-regression analysis
(Mean values and standard deviations)
Source Country Latitude
Age (years)
Male
(%)
Duration
(weeks)
Participants
(n per group)
Supplemental
vitamin D3
dose (IU/d)
Habitual
vitamin D
intake (IU/d)
Total
vitamin D
intake (IU/d)
Baseline
25(OH)D
(nmol/l)
Achieved
25(OH)D
(nmol/l)
Randomisation
reported
Dose
check*
Compliance
reported
Analytical
method†Mean Range Mean SD Mean SD
Ala-Houhala
et al.(24)
Finland 618N 9 10–15 45 56 24 400 200‡ 600 49·2 19·0 77·9 23·7 Yes No No CPBA
27 0 200‡ 200 45·9 15·5 43·2 19·5 – – – –
Barnes
et al.(26)
UK 558N 21 18–27 50 8 15 600 65 665 47·9 16·0 85·6 24·5 Yes No No EIA
12 0 96 96 55·5 18·6 48·3 16·8 – – – –
Cashman
et al.(13)
Ireland 51–558N 30 20–40 50 22 53 600 144 744 75·9 24·8 69·0 18·6 Yes Yes Yes EIA
57 400 140 540 72·2 26·8 60·0 13·4 – – – –
48 200 172 372 60·0 29·4 49·7 11·4 – – – –
57 0 136 136 65·7 26·5 37·4 12·2 – – – –
Cashman
et al.(14)
Ireland 51–558N 71 64þ 40 22 48 600 192 792 55·1 22·8 73·8 20·0 Yes Yes Yes EIA
53 400 168 568 54·3 21·8 69·5 17·0 – – – –
48 200 164 364 51·8 22·1 53·2 17·0 – – – –
55 0 188 188 58·8 25·9 58·8 17·1 – – – –
Cashman
et al.(15)
Finland
and
Denmark
588N§ 11·4k 0 52 49 400 156 556 58·4 13·9 58·8 10·9 Yes Yes Yes HPLC
49 200 156 356 57·4 12·4 47·6 8·0 – – – –
46 0 148 148 54·5 14·8 31·0 10·0 – – – –
Honkanen
et al.(43 ){
Finland 638N 70 67–72 0 11 30 1800 380‡ 2180 42·8 19·6 80·7 15·4 Yes No No HPLC
27 0 380‡ 380 36·0 13·3 23·3 13·3 – – – –
Meier et al.(50) Germany 508N 56 33–78 33 26 27 500 128** 628 75·1 28·5 87·6 20·0 Yes No No RIA
16 0 128** 128 76·9 23·2 51·2 21·2 – – – –
Pfeifer
et al.(55)
Germany 528N 74 70þ 0 8 74 800 128** 928 25·7 13·6 64·8 27·4 Yes No Yes RIA
77 0 128** 128 24·6 12·1 44·4 27·4 – – – –
Smith
et al.(58)
Antarctica 788S 42k 59 20 18 2000 302 2302 45·0 14·0 71·0 23·0 Yes Yes Yes RIA
19 1000 329 1329 44·0 19·0 63·0 25·0 – – – –
18 400 356 756 44·0 18·0 57·0 15·0 – – – –
7 0 334 334 36·0 17·0 34·0 12·0 – – – –
Viljakainen
et al.(21)
Finland 618N 71 65–85 0 12 13 800 388 1188 44·1 13·5 70·2 13·5 Yes No No HPLC
11 400 424 824 46·5 10·2 60·4 10·2 – – – –
13 200 388 588 46·0 10·2 55·0 10·2 – – – –
12 0 436 436 52·2 19·9 43·9 19·9 – – – –
Viljakainen
et al.(62)
Finland 618N 29 21–49 100 25 16 800 344 1144 60·3 11·6 90·1 11·6 Yes Yes Yes EIA
16 400 304 704 62·3 13·6 75·6 13·6 – – – –
16 0 264 264 64·7 18·5 52·2 18·5 – – – –
25(OH)D, 25-hydroxyvitamin D; CBPA, competitive binding protein assay; EIA, enzyme-linked immunoassay.
* Dose of vitamin D confirmed independently by analysis.
† Analytical methods for analysing circulating 25(OH)D levels: EIA; CBPA; HPLC.
‡ Intake estimated from Andersen et al.(76).
§ An average latitude was taken from Helsinki, Finland (618N) and Copenhagen, Denmark (558N).
k Mean age is given where range is not available.
{ Data was extracted from the ‘outpatient’ group of the study only.
** Intake estimate was obtained from Flynn et al.(71).
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eleven studies were carried out in northern Europe (.49·58N)
and one in Antarctica (788S), seven studies were in latitudes
between 40 and 49·58N, of which six were in the USA and
one from Europe (Switzerland). Six of the twelve RCT in
.49·58N and four of the seven RCT at .408N to ,49·58N
were included in the comprehensive systematic review by
the Ottawa group(22) and all had a Jadad score $3. The
remaining RCT were not within the timeframe of that syste-
matic review and thus do not have a Jadad score, but were
all included in the IOM analysis(8).
Meta-regression of the response of serum
25-hydroxyvitamin D to total vitamin D intake
The listing of winter-based RCT at $49·58N and 788S (n 12),
identified through the search strategy and data collection
of the present study, differed modestly from those (n 9)
used in the IOM DRI committee’s meta-regression analyses:
seven RCT(13,14,21,24,58,61,62) were common to both analyses,
three RCT(63–65), which were used by the DRI committee,
were excluded from the present analysis as they were too
short in duration (4–5 weeks), whereas we included five
RCT(26,43,50,51,55) that fit with the inclusion criteria of the pre-
sent study, but were not included in the DRI committee’s
analysis (possibly because Ca was co-administered, but this
has not been shown to influence the response of serum
25(OH)D to vitamin D in a meta-analysis(17) or experimentally
in an intervention study(66), or because the RCT was after the
IOM’s timeframe(51)). In the case of two RCT, combined data
from 11-year-old girls in the RCT by Viljakainen et al.(61) and
Mølgaard et al.(51), who were on the vitamin D intervention
during September/October to March/April (a subset of the
entire group) were presented recently by Cashman et al.(15).
We also checked the literature for any relevant studies
between 1 December 2010 and 28 February 2011, but none
of the three studies published during this time frame(67–69)
could be included in the present regression analysis.
Weighted linear model meta-regression analyses of Ln
total vitamin D intake v. achieved serum or plasma 25(OH)D
concentration (and setting y0 at 0 nmol/l serum 25(OH)D)
from winter-time-only RCT stratified by latitude showed that
in those performed at latitudes .40 to ,49·58N or $49·58N
and 788S, the interaction term between age and the Ln of
total vitamin D intake (P¼0·922 and 0·472, respectively), as
well as the main effect of age (P¼0·652 and 0·325, respec-
tively) were non-significant. Therefore, because there was
no age effect in the response of serum 25(OH)D level to
Ln total intake of vitamin D, a single, combined regression
analysis was carried out on the data from RCT at both latitude
groupings separately.
With RCT at .40 to ,49·58N (n 7), the present analysis
yielded the predictive equation of achieved serum 25(OH)D
in nmol/l ¼ 12·6 Ln (total vitamin D intake) (Table 2). These
RCT were conducted during the winter period, as defined
broadly by the DRI committee as September to June or
part thereof(8). The regression analysis was also run after
omitting RCT whose end point was beyond April (n 2),
which yielded the predictive equation of achieved serum
25(OH)D in nmol/l ¼ 11·4 Ln (total vitamin D intake).
A single, combined regression analysis was also carried out
with data from winter-time-only (April, the latest end date)
RCT at latitudes $49·58N and 788S, and resulted in the pre-
dictive equation of achieved serum 25(OH)D in nmol/l ¼ 9·2
Ln (total vitamin D intake) (Table 2 and Fig. 2). Using the
combined regression predicted 95 % lower CI of y ¼ 8·5
Ln (total vitamin D intake) and inputting a total intake
value of 600 IU/d (the RDA for those aged 1–70 years(8))
would predict an achieved serum 25(OH)D of 54·4 nmol/l.
Using the same equation, but in reverse, to predict the total
intake of vitamin D that would achieve a serum 25(OH)D
of 50 nmol/l (the concentration that would meet the needs
of 97·5 % of the population(8)), the required total intake of
vitamin D dropped dramatically to 359 IU/d.
As an alternative to the curvilinear relationship arising
from the Ln-transformed intake data, if non-transformed
total vitamin D intake (and limiting it to a maximum of
1400 IU/d on the basis of Aloia et al.(23)) was used, a more
linear relationship resulted (Fig. 2). The interaction term
between age and total vitamin D intake (P¼0·213), as well
as the main effect of age (P¼0·196) were non-significant,
allowing for a single, combined regression analysis
that resulted in the predictive equation of achieved serum
Table 2. Predictive regression equations of achieved winter serum 25-hydroxyvitamin D (s25(OH)D) as a function of natural log (Ln) and linear total
vitamin D intake
Study grouping
Predicted mean (95 %
lower CI) equations
Predicted s25(OH)D
(nmol/l) at 600 IU/d*
Predicted RDA
(IU/d) at s25(OH)D
of 50 nmol/l*
Predicted RDA
(IU/d) at s25(OH)D
of 40 nmol/l*
Ln model
Winter-based RCT .40
to ,49·58N (n† 7)
y ¼ 12·6 Ln (total vitamin D intake)
(y ¼ 11·7 Ln (total vitamin D intake))
74·8 72 31
Winter-based RCT $49·58N
and 788S (n† 12)
y ¼ 9·2 Ln (total vitamin D intake)
(y ¼ 8·5 Ln (total vitamin D intake))
54·4 359 111
Linear model
Winter-based RCT $49·58N
and 788S (n† 12)
y ¼ 0·044 (total vitamin D
intake) þ 33·035‡
55·2 480 260
RCT, randomised controlled trials; y, achieved serum 25(OH)D (nmol/l) in winter.
* Using the 95 % lower CI regression equation.
† Refers to number of RCT.
‡ Maximum total vitamin D intake was limited to 1400 IU/d (35mg/d).
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25(OH)D in nmol/l ¼ 0·044 (total vitamin D intake) þ 33·035.
The 95 % lower CI predictive regression values from the linear
intake–status relationship predicted an achieved serum
25(OH)D of 55·2 nmol/l, at a total intake value of 600 IU/d.
The lower CI regression equations predicted the total intake
of vitamin D that would achieve a serum 25(OH)D of
50 nmol/l of 480 IU/d (Table 2).
Using the Ln and linear lower CI regression equations,
it was predicted that the total intake of vitamin D would
achieve a serum 25(OH)D of 40 nmol/l at 111 and 260 IU/d,
respectively.
Regression analysis using the combined data from two
vitamin D randomised control trials
The predicted RDA estimates for vitamin D at two target
serum 25(OH)D concentrations (i.e. 40 and 50 nmol/l) using
the 95 % lower CI meta-regression analysis with group means
(n 8) and regression analysis with 95 % lower CI and 95 %
range of individual combined data (total n 463; maximum
total vitamin D intake ¼ 1310 IU/d; hence, all data were
included) from the two RCT with adults(13) and older adults(14)
are shown in Table 3. The RDA estimates from the meta-
regression and regression of individual data, which both used
the 95 % lower CI, were dramatically lower than that from the
regression model of individual data that used the 95 % range.
After seeing the magnitude of the difference in the require-
ment estimates arising from use of 95 % lower CI and 95 %
range, we also went back and for comparative purposes
applied a 95 % range to the linear meta-regression analysis
of twelve winter-based RCT at .49·58N, although caution is
warranted when applying a 95 % range when the number of
data points are relatively low (n 30). This analysis predicted
that the total intake of vitamin D that would achieve a
serum 25(OH)D of 50 nmol/l was 930 IU/d (v. 480 IU/d with
the 95 % lower CI).
Table 3. Predicted RDA estimates using linear regression models of
group means and individual data from two winter-based vitamin D
randomised controlled trials (RCT) at $528N
Regression approach
RDA estimate
(IU/d) at 50 nmol/l
25(OH)D
RDA estimate
(IU/d) at 40 nmol/l
25(OH)D
Combined meta-regression
analysis of group means
from two RCT (n* 8) and
use of 95 % lower CI
395 235
Regression analysis of
individual data (n† 463)
and use of 95 % lower CI
320 140
Regression analysis of
individual data (n† 463)
and use of 95 % range
1040 830
25(OH)D, 25-hydroxyvitamin D.
* Refers to eight group means from two RCT (young adults, Cashman et al.(13);
and older adults, Cashman et al.(14)).
† Refers to number of combined individuals within the two RCT.
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Fig. 2. Response of serum 25-hydroxyvitamin D (25(OH)D) level to total intake of vitamin D in northern latitudes in Europe (.49·58N) and Antarctica (788S) during
their respective winter seasons, when effective sun exposure for endogenous vitamin D synthesis is minimal. Mean responses (white lines) with 95 % CI using a
weighted linear meta-regression model following either a natural logarithmic transformation (dark gray shading, curvilinear model) or no transformation (pale gray
shading, linear model) of total vitamin D intake data. The maximum total intake data point in the linear model was ,1400 IU/d (35mg/d). A line is plotted at
50 nmol/l serum 25(OH)D for illustrative purposes.
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Discussion
The new IOM DRI values for vitamin D(8) relied heavily on
data from eight northern European (plus one from Antarctica)
winter-based vitamin D RCT and thus would appear to be
highly relevant to Europe in terms of a re-evaluation of its
vitamin D dietary reference values (i.e. population reference
intakes; PRI) and indeed those of its constituent member
states/regions. Using the systematic review approach of the
present study, we identified and extracted data from eleven
relevant European-based RCT (plus one RCT from Antarctica)
with vitamin D3, which were conducted at latitudes $49·58N
during winter, in line with the approach used by the IOM
DRI committee. Despite some differences in the final collec-
tion of RCT included in the present regression analysis relative
to that in the DRI committee’s analysis (as outlined pre-
viously), the 95 % lower CI predictive equations of achieved
25(OH)D v. Ln total vitamin D intake were very close.
The DRI committee choose to apply the curvilinear Ln
model to the intake–status data from the RCT to account for
the more blunted response of serum 25(OH)D to high intakes
of vitamin D(8). This non-linear response of serum 25(OH)D to
vitamin D intake is to be expected on the basis of metabolic
kinetics. Heaney et al.(70) showed that the relationship
between serum vitamin D3 and 25(OH)D concentrations is
biphasic due to the fact that hepatic 25-hydroxylase becomes
saturated and the reaction switches from first to zero order.
Even though the lower limit CI predictive equations arising
from the Ln model overshoots the target serum 25(OH)D
mark of 50 nmol/l at the 600 IU/d vitamin D intake level
(e.g. 56 nmol/l in the DRI analysis(8), 54 nmol/l in the present
analysis), the committee used this intake estimate to allow
for some uncertainties and limitations within the analysis(8).
Should one choose to use 50 nmol/l as the target concen-
tration of serum 25(OH)D in these equations, then the dietary
requirement estimate is 313 IU/d (359 IU/d in the present
analysis), and alternatively, if one uses 40 nmol/l, it is only
99 IU/d (111 IU/d in the present analysis). The Ln model has
a steep decline in achieved serum 25(OH)D concentrations
at total vitamin D intakes, particularly at the lower end of
intakes, and at zero intake, the achieved serum 25(OH)D
was 0 nmol/l due to a forcing of the model to avoid a negative
predicted value for achieved serum 25(OH)D levels(8).
However, it is also worth considering whether it is likely
that someone with no vitamin D intake during winter (if that
were possible) might still have a serum 25(OH)D concen-
tration greater than zero as a consequence of tissues stores?
For example, the adult subject with lowest total vitamin D
intake (24 IU/d) in our vitamin D intervention study in 20- to
40-year-old adult group(13) had a winter serum 25(OH)D of
31·6 nmol/l.
Others, including ourselves(17), have reported serum
25(OH)D response estimates to vitamin D supplementation
from RCT based on a linear analysis(22,41), but with doses up
to 2000 IU/d(22) and even 10 000 IU/d(41). This clearly does
not take account of the smoothening in the response of
serum 25(OH)D to higher intakes of vitamin D. Therefore,
in the present analysis, we also performed a linear analysis
of the intake–status data, but excluded intake data points
(n 2) in excess of 1400 IU/d on basis of Aloia et al.(23), who
showed that the response slope of serum 25(OH)D becomes
constant at this level. In Ireland and the UK, as well as in
several other European member states(71), the 95th percentile
of total vitamin D intake in national nutrition surveys is
generally less than 600 IU/d; thus, a range of 0–1400 IU/d
brackets the nutritional intake of vitamin D seen in the
population. Using an intake of 600 IU/d in the lower limit CI
predictive linear regression equation, the predicted serum
25(OH)D concentration was 55 nmol/l – similar to that from
the Ln models, and providing further support to the DRI
committee’s findings. However, an intake of 260 and 480 IU/d
was required to achieve serum 25(OH)D concentrations of
40 and 50 nmol/l, respectively (2·3- and 1·4-fold higher than
that predicted from the Ln model, respectively).
Clearly, the shape of the intake–status relationship
has an important bearing on the predicted RDA estimates
for vitamin D at serum 25(OH)D target concentrations
#50 nmol/l. However, and maybe more importantly, irres-
pective of whether a Ln or linear model is applied in these
meta-regression analyses, estimates of 359 or 480 IU/d vitamin
D requirements, respectively, to cover the needs of 97·5 %
of the population in terms of maintaining serum 25(OH)D
.50 nmol/l does not fit well with our estimates from experi-
mental studies that suggest that 988–1120 IU/d would be
required(13,14). The use of CI in meta-regression analyses
provides some estimate of the variability about the fitted
response line, but does not provide any estimate of the
variability between individuals in terms of dietary intake of
vitamin D needed to achieve a serum 25(OH)D concentration
(i.e. an estimate of the range). This was illustrated in the
present study, wherein RDA estimates from either the meta-
regression or regression of individual data that used the 95 %
lower CI were dramatically lower than the model that used
the 95 % range. The former variability term gives 95 % surety
that the average serum 25(OH)D level in the adult population
is above 50 nmol/l at a certain intake of vitamin D, whereas
the latter can be used to take account of inter-individual
variability on intake required to reach a chosen serum
25(OH)D cutoff. The importance of this inter-individual varia-
bility term (95 % range) can also be seen if one compares the
estimates from our RCT in young adults(13) and older adults(14),
which incorporated the range, and suggest that 346 IU/d of
vitamin D are required to keep winter time serum 25(OH)D
levels .25 nmol/l in 97·5 % of the population, whereas the
model with lower 95 % CI predicts that 0 IU/d intake will suf-
fice. We have reported previously that if one tests the former
estimate within the nationally representative UK National Diet
and Nutrition Survey databases of adults and older adults,
there was a 11–18·4 % prevalence of serum 25(OH)D below
25 nmol/l during late winter/early spring in those with intakes
below 346 IU/d and only 0–2·9 % prevalence in those with
intakes above this estimate(72), suggesting that this intake
did indeed protect the vast majority of the adult population
from vitamin D deficiency.
The present regression analysis also predicted a higher
response of serum 25(OH)D to total vitamin D intake at
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lower (40–49·58N) than at higher latitudes ($49·58N/S), in line
with the DRI committee’s findings(8). Although the reason(s)
for this could not be explored in the present analysis, it may
relate to differences in the capacity for dermal synthesis
during extended winter in these different regions and/or
stores of vitamin D arising from previous summer UVB sun
exposure. Nevertheless, it may be relevant to Europe, much
of which resides between 40 and .708N. The present analysis
had a number of limitations arising from the available data on
which to base the meta-regression. Most of the subjects in the
twelve RCT that met with the inclusion criteria of the present
study were Caucasians, and thus does not reflect the ethnic
diversity that exists in many European member states.
Recent data from national nutrition and health surveys in the
USA and Canada clearly show that risk of serum 25(OH)D
concentrations below 30 and 50 nmol/l was higher in non-
white than in white persons(73,74). The DRI committee
highlighted the need for a greater understanding of how skin
pigmentation influences vitamin D synthesis, and highlighted
that South Asian and Middle Eastern immigrant groups may
be a particular concern(8). Finally, the quality of vitamin D
intake data in the meta-regression analysis may be a limitation,
as in some cases national intake vitamin D data had to be
used as a surrogate in those studies that did not measure/
report intake data. Furthermore, there can be considerable
differences in food compositional data for vitamin D across
countries(75).
In conclusion, although the relation of serum 25(OH)D to
vitamin D intake is critical to the establishment of dietary
requirements for vitamin D, the model used to describe this
relationship needs to be configured to take into account
important considerations such as target serum 25(OH)D
concentration, range of intakes of vitamin D within the popu-
lation and inter-individual variability. There may be additional
benefit from use of individual data from vitamin D RCT, if
these were available, to augment the meta-analyses approach.
Acknowledgements
The present study was carried out with partial financial sup-
port from the Commission of the European Communities,
specific RTD Programme ‘Quality of Life and Management
of Living Resources’, within the 6th Framework Programme
(contract no. FP6-036196-2 EURRECA: EURopean micro-
nutrient RECommendations Aligned). This paper does not
necessarily reflect the views of the Commission and in no
way anticipates future policy in this area. K. M. S. and
K. D. C. assessed the studies for inclusion, extracted data
and assessed validity; K. M. S., A. P. F. and K. D. C. con-
ducted meta-regression and regression; K. M. S. and K. D.
C. tabulated data; K. M. S., M. K. and K. D. C. wrote the
manuscript. The authors declare no conflicts of interest.
References
1. UK Department of Health (1998) Nutrition and Bone Health:
With Particular Reference to Calcium and Vitamin D. Report
on Health and Social Subjects (49). London: The Stationery
Office.
2. Lips P (2001) Vitamin D deficiency and secondary hyper-
parathyroidism in the elderly: consequences for bone loss
and fractures and therapeutic implications. Endocr Rev 22,
477–501.
3. Parfitt AM, Gallagher JC, Heaney RP, et al. (1982) Vitamin D
and bone health in the elderly. Am J Clin Nutr 36,
1014–1031.
4. Ooms ME, Lips P, Roos JC, et al. (1995) Vitamin D status and
sex hormone binding globulin: determinants of bone turn-
over and bone mineral density in elderly women. J Bone
Miner Res 10, 1177–1184.
5. Zittermann A (2003) Vitamin D in preventive medicine: are
we ignoring the evidence? Br J Nutr 89, 552–572.
6. Holick MF (2004) Sunlight and vitamin D for bone health
and prevention of autoimmune diseases, cancers and cardio-
vascular disease. Am J Clin Nutr 80, 1678S–1688S.
7. Cashman KD (2007) Calcium and vitamin D. Novartis
Found Symp 282, 123–138.
8. Institute of Medicine Food and Nutrition Board (2011)
Dietary Reference Intakes for Calcium and Vitamin D.
Washington, DC: National Academy Press.
9. Department of Health (1991) Dietary Reference Values for
Food Energy and Nutrients for the United Kingdom. Report
on Health and Social Subjects (41). London: Her Majesty’s
Stationery Office.
10. Nordic Council of Ministers (2004) Nordic Nutrition Rec-
ommendations 2004. Integrating Nutrition and Physical
Activity. Copenhagen: Nordic Council of Ministers.
11. Commission of the European Communities (1993)
Vitamin D. In Nutrient and Energy Intakes of the European
Community. Report of the Scientific Committee for Food
(31st series), pp. 132–139. Brussels: Commission of the
European Communities.
12. Agency for Healthcare Research and Quality (AHRQ)
(2009) Vitamin D and calcium: a systematic review of
health outcomes. AHRQ Publication No. 09-E015. http://
www.ahrq.gov/clinic/tp/vitadcaltp.htm (accessed 28 Octo-
ber 2010).
13. Cashman KD, Hill TR, Lucey AJ, et al. (2008) Estimation of
the dietary requirement for vitamin D in healthy adults.
Am J Clin Nutr 88, 1535–1542.
14. Cashman KD, Wallace JM, Horigan G, et al. (2009)
Estimation of the dietary requirement for vitamin D in free-
living adults $64 y of age. Am J Clin Nutr 89, 1366–1374.
15. Cashman KD, Fitzgerald AP, Viljakainen HT, et al. (2011)
Estimation of the dietary requirement for vitamin D in
healthy adolescent white girls. Am J Clin Nutr 93, 549–555.
16. Hooper L, Ashton K, Harvey LJ, et al. (2009) Assessing
potential biomarkers of micronutrient status by using a
systematic review methodology: methods. Am J Clin Nutr
89, 1953S–1959S.
17. Seamans KM & Cashman KD (2009) Existing and potentially
novel functional markers of vitamin D status: a systematic
review. Am J Clin Nutr 89, 1997S–2008S.
18. Cashman KD (2011) The role of vitamers and dietary-based
metabolites of vitamin D in prevention of vitamin D
deficiency. Food Nutr Res (In the Press).
19. Lanham-New S, Vieth R & Heaney R (2010) Vitamin D2
and vitamin D3 comparisons: fundamentally flawed study
methodology. Am J Clin Nutr 92, 999.
20. Harris SS & Dawson-Hughes B (2002) Plasma vitamin D
and 25OHD responses of young and old men to supple-
mentation with vitamin D3. J Am Coll Nutr 21, 357–362.
K. D. Cashman et al.1646
B
ri
ti
sh
Jo
u
rn
al
o
f
N
u
tr
it
io
n
21. Viljakainen HT, Palssa A, Ka¨rkka¨inen M, et al. (2006)
How much vitamin D3 do the elderly need? J Am Coll Nutr
25, 429–435.
22. Cranney A, Horsley T, O’Donnell S, et al. (2007) Effective-
ness and safety of vitamin D in relation to bone health. In
Evidence Report/Technology Assessment No. 158 (Prepared
by the University of Ottawa Evidence-based Practice Center
(UO-EPC) under Contract No. 290-02-0021, AHRQ Publi-
cation No. 07-E013: Agency for Healthcare Research and
Quality Rockville, MD.
23. Aloia JF, Patel M, Dimaano R, et al. (2008) Vitamin D intake
to attain a desired serum 25-hydroxyvitamin D concen-
tration. Am J Clin Nutr 87, 1952–1958.
24. Ala-Houhala M, Koskinen T, Koskinen M, et al. (1988)
Double blind study on the need for vitamin D supplemen-
tation in prepubertal children. Acta Paediatr Scand 77,
89–93.
25. Andersen R, Molgaard C, Skovgaard LT, et al. (2008) Effect of
vitamin D supplementation on bone and vitamin D status
among Pakistani immigrants in Denmark: a randomised
double-blinded placebo-controlled intervention study. Br J
Nutr 100, 197–207.
26. Barnes MS, Robson PJ, Bonham MP, et al. (2006) Effect of
vitamin D supplementation on vitamin D status and bone
turnover markers in young adults. Eur J Clin Nutr 60,
727–733.
27. Biancuzzo RM, Young A, Dibuld D, et al. (2010) Fortification
of orange juice with vitamin D(2) or vitamin D(3) is less
effective as an oral supplement in maintaining vitamin D
status in adults. Am J Clin Nutr 91, 1621–1626.
28. Bischoff HA, Sta¨helin HB, Dick W, et al. (2003) Effects of
vitamin D and calcium supplementation on falls: a random-
ized controlled trial. J Bone Miner Res 18, 343–351.
29. Blum M, Dallal GE & Dawson-Hughes B (2008) Body size
and serum 25 hydroxy vitamin D response to oral sup-
plements in healthy older adults. J Am Coll Nutr 27,
274–279.
30. Bolton-Smith C, McMurdo ME, Paterson CR, et al. (2007)
Two-year randomized controlled trial of vitamin K1 (phyllo-
quinone) and vitamin D3 plus calcium on the bone health of
older women. J Bone Miner Res 22, 509–519.
31. Brazier M, Grados F, Mathieu M, et al. (2005) Clinical and
laboratory safety of one year’s use of a combination
calcium þ vitamin D tablet in ambulatory elderly women
with vitamin D insufficiency: results of a multicenter, ran-
domized, double-blind, placebo-controlled study. Clin Ther
27, 1885–1893.
32. Brazier M, Kamel S, Lorget F, et al. (2002) Biological effects
of supplementation with vitamin D and calcium in post-
menopausal women with low bone mass receiving alendro-
nate. Clin Drug Investig 22, 849–857.
33. Chapuy MC, Arlot ME, Duboeuf F, et al. (1992) Vitamin D3
and calcium to prevent hip fractures in the elderly women.
N Engl J Med 327, 1637–1632.
34. Chel V, Wijnhoven HA, Smit JH, et al. (2008) Efficacy of
different doses and time intervals of oral vitamin D sup-
plementation with or without calcium in elderly nursing
home residents. Osteoporos Int 19, 663–671.
35. Dawson-Hughes B, Harris SS, Krall EA, et al. (1997) Effect of
calcium and vitamin D supplementation on bone density
in men and women 65 years of age or older. N Engl J Med
337, 670–676.
36. Dawson-Hughes B, Dallal GE, Krall EA, et al. (1991) Effect of
vitamin D supplementation on wintertime and overall bone
loss in healthy postmenopausal women. Ann Intern Med
115, 505–512.
37. Fedirko V, Bostick RM, Flanders WD, et al. (2009) Effects of
vitamin D and calcium on proliferation and differentiation in
normal colon mucosa: a randomized clinical trial. Cancer
Epidemiol Biomarkers Prev 18, 2933–2941.
38. Grados F, Brazier M, Kamel S, et al. (2003) Prediction of
bone mass density variation by bone remodeling markers
in postmenopausal women with vitamin D insufficiency
treated with calcium and vitamin D supplementation. J Clin
Endocrinol Metab 88, 5175–5179.
39. Grant AM, Avenell A, Campbell MK, et al. (2005) Oral
vitamin D3 and calcium for secondary prevention of
low-trauma fractures in elderly people (Randomized Eva-
luation of Calcium Or vitamin D, RECORD): a randomized
placebo-controlled trial. Lancet 365, 1621–1628.
40. Heikkinen A, Parviainen MT, Tuppurainen MT, et al.
(1998) Effects of postmenopausal hormone replacement
therapy with and without vitamin D3 on circulating levels
of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D.
Calcif Tissue Int 62, 26–30.
41. Heaney RP, Davies KM, Chen TC, et al. (2003) Human serum
25-hydroxycholecalciferol response to extended oral dosing
with cholecalciferol. Am J Clin Nutr 77, 204–210.
42. Himmelstein S, Clemens TL, Rubin A, et al. (1990) Vitamin D
supplementation in elderly nursing home residents increases
25(OH)D but not 1,25(OH)2D. Am J Clin Nutr 52, 701–706.
43. Honkanen R, Alhava E, Parviainen M, et al. (1990) The
necessity and safety of calcium and vitamin D in the elderly.
J Am Geriatr Soc 38, 862–866.
44. Karkkainen MK, Tuppurainen M, Salovaara K, et al. (2010)
Does daily vitamin D 800 IU and calcium 1000 mg sup-
plementation decrease the risk of falling in ambulatory
women aged 65–71 years? A 3-year randomized popu-
lation-based trial (OSTPRE-FPS). Maturitas 65, 359–365.
45. Kenny AM, Biskup B & Robbins B (2003) Effects of vitamin D
supplementation on strength, physical function, and health
perception in older, community-dwelling men. J Am Geriatr
Soc 51, 1762–1767.
46. Krieg MA, Jacquet AF, Bremgartner M, et al. (1999) Effect of
supplementation with vitamin D3 and calcium on quanti-
tative ultrasound of bone in elderly institutionalized
women: a longitudinal study. Osteoporos Int 9, 483–488.
47. Lappe JM, Travers-Gustafson D & Davies KM (2007)
Vitamin D and calcium supplementation reduces cancer
risk: results of a randomized trial. Am J Clin Nutr 85,
1586–1591.
48. Li-Ng M, Aloia JF, Pollack S, et al. (2009) A randomized con-
trolled trial of vitamin D3 supplementation for the prevention
of symptomatic upper respiratory tract infections. Epidemiol
Infect 137, 1396–1404.
49. Lips P, Graafmans WC, Ooms ME, et al. (1996) Vitamin D
supplementation and fracture incidence in elderly persons.
A randomized, placebo-controlled clinical trial. Ann Intern
Med 124, 400–406.
50. Meier C, Woitge HW, Witte K, et al. (2004) Supplementation
with oral vitamin D3 and calcium during winter prevents
seasonal bone loss: a randomized controlled open-label
prospective trial. J Bone Miner Res 19, 1221–1230.
51. Mølgaard C, Larnkjaer A, Cashman KD, et al. (2010) Does
vitamin D supplementation of healthy Danish Caucasian
girls affect bone turnover and bone mineralization? Bone
46, 432–439.
52. Nelson ML, Blum JM, Hollis BW, et al. (2009) Supplements of
20mg/d cholecalciferol optimized serum 25-hydroxyvitamin
D concentrations in 80 % of premenopausal women in
winter. J Nutr 139, 540–546.
Vitamin D intake–status relationship 1647
B
ri
ti
sh
Jo
u
rn
al
o
f
N
u
tr
it
io
n
53. Orwoll ES, Weigel RM, Oviatt SK, et al. (1988) Calcium and
cholecalciferol: effects of small supplements in normal
men. Am J Clin Nutr 48, 127–130.
54. Patel R, Collins D, Bullock S, et al. (2001) The effect of
season and vitamin D supplementation on bone mineral
density in healthy women: a double-masked crossover
study. Osteoporos Int 12, 319–325.
55. Pfeifer M, Begerow B, Minne HW, et al. (2001) Effects of a
short-term vitamin D(3) and calcium supplementation on
blood pressure and parathyroid hormone levels in elderly
women. J Clin Endocrinol Metab 86, 1633–1637.
56. Schaafsma A, Muskiet FA, Storm H, et al. (2000) Vitamin D(3)
and vitamin K(1) supplementation of Dutch postmenopausal
women with normal and low bone mineral densities: effects
on serum 25-hydroxyvitamin D and carboxylated osteocal-
cin. Eur J Clin Nutr 54, 626–631.
57. Schleithoff SS, Zittermann A, Tenderich G, et al. (2006)
Vitamin D supplementation improves cytokine profiles
in patients with congestive heart failure: a double-blind,
randomized, placebo-controlled trial. Am J Clin Nutr 83,
754–759.
58. Smith SM, Gardner KK, Locke J, et al. (2009) Vitamin D
supplementation during Antarctic winter. Am J Clin Nutr
89, 1092–1098.
59. Sorva A, Risteli J, Risteli L, et al. (1991) Effects of vitamin D
and calcium on markers of bone metabolism in geriatric
patients with low serum 25-hydroxyvitamin D levels. Calcif
Tissue Int 49 (Suppl.), S88–S89.
60. Talwar SA, Aloia JF, Pollack S, et al. (2007) Dose response
to vitamin D supplementation among postmenopausal
African American women. Am J Clin Nutr 86, 1657–1662.
61. Viljakainen HT, Natri AM, Ka¨rkka¨inen M, et al. (2006) A posi-
tive dose–response effect of vitamin D supplementation on
site-specific bone mineral augmentation in adolescent girls:
a double-blinded randomized placebo-controlled 1-year
intervention. J Bone Miner Res 21, 836–844.
62. Viljakainen HT, Vaisanen M, Kemi V, et al. (2009) Wintertime
vitamin D supplementation inhibits seasonal variation of
calcitropic hormones and maintains bone turnover in
healthy men. J Bone Miner Res 24, 346–352.
63. Schou AJ, Heuck C & Wolthers OD (2003) A randomized,
controlled lower leg growth study of vitamin D supple-
mentation to healthy children during the winter season.
Ann Hum Biol 30, 214–219.
64. Larsen ER, Mosekilde L & Foldspang A (2004) Vitamin D
and calcium supplementation prevents osteoporotic frac-
tures in elderly community dwelling residents: a pragmatic
population-based 3-year intervention study. J Bone Miner
Res 19, 370–378.
65. van der Klis FR, Jonxis JH, van Doormaal JJ, et al. (1996)
Changes in vitamin-D metabolites and parathyroid hormone
in plasma following cholecalciferol administration to pre-
and postmenopausal women in the Netherlands in early
spring and to postmenopausal women in Curac¸ao. Br J
Nutr 75, 637–646.
66. McCullough ML, Bostick RM, Daniel CR, et al. (2009)
Vitamin D status and impact of vitamin D3 and/or calcium
supplementation in a randomized pilot study in the South-
eastern United States. J Am Coll Nutr 28, 678–686.
67. Cherniack EP, Florez HJ, Hollis BW, et al. (2011) The
response of elderly veterans to daily vitamin D3 supple-
mentation of 2,000 IU: a pilot efficacy study. J Am Geriatr
Soc 59, 286–290.
68. Ka¨rkka¨inen M, Tuppurainen M, Salovaara K, et al. (2010)
Effect of calcium and vitamin D supplementation on bone
mineral density in women aged 65–71 years: a 3-year ran-
domized population-based trial (OSTPRE-FPS). Osteoporos
Int 21, 2047–2055.
69. Austin N, Devine A, Bruce D, et al. (2010) A randomized
controlled trial of the effects of vitamin D on muscle strength
and mobility in older women with vitamin D insufficiency.
J Am Geriatr Soc 58, 2063–2068.
70. Heaney RP, Armas LA, Shary JR, et al. (2008) 25-Hydroxy-
lation of vitamin D3: relation to circulating vitamin D3
under various input conditions. Am J Clin Nutr 87,
1738–1742.
71. Flynn A, Hirvonen T, Mensink GB, et al. (2009) Intake of
selected nutrients from foods, from fortification and from
supplements in various European countries. Food Nutr Res
12, 53.
72. Cashman K & Kiely M (2009) Author reply to Letter to
editor ‘Experimentally observed vitamin D requirements
are higher than extrapolated one’. Am J Clin Nutr 90,
1115–1116.
73. Looker AC, Johnson CL, Lacher DA, et al. (2011) Vitamin D
status: United States, 2001–2006. NCHS Data Brief 59, 1–8.
74. Whiting SJ, Langlois KA, Vatanparast H, et al. (2011) The
vitamin D status of Canadians relative to the 2011 Dietary
Reference Intakes: an examination in children and adults
with and without supplement use. Am J Clin Nutr 94,
128–135.
75. EuroFIR (2011) Food Composition Databases. http://www.
eurofir.net/eurofir_knowledge/european_databases (accessed
25 July 2011).
76. Andersen R, Mølgaard C, Skovgaard LT, et al. (2005)
Teenage girls and elderly women living in northern
Europe have low winter vitamin D status. Eur J Clin Nutr
59, 533–541.
K. D. Cashman et al.1648
B
ri
ti
sh
Jo
u
rn
al
o
f
N
u
tr
it
io
n
